New Computational Tools for Modeling Chronic Myelogenous Leukemia

In this paper, we consider a system of nonlinear delay-differential equations (DDEs) which models the dynamics of the interaction between chronic myelogenous leukemia (CML), imatinib, and the anti-leukemia immune response. Because of the chaotic nature of the dynamics and the sparse nature of experimental data, we look for ways to use computation to analyze the model without employing direct numerical simulation. In particular, we develop several tools us- ing Lyapunov-Krasovskii analysis that allow us to test the robustness of the model with respect to uncertainty in patient parameters. The methods developed in this paper are applied to understand- ing which model parameters primarily affect the dynamics of the anti-leukemia immune response during imatinib treatment. The goal of this research is to aid the development of more efficient modeling approaches and more effective treatment strategies in cancer therapy.

[1]  Silviu-Iulian Niculescu,et al.  ON STABILITY OF A COMBINED GLEEVEC AND IMMUNE MODEL IN CHRONIC LEUKEMIA: EXPLOITING DELAY SYSTEM STRUCTURE , 2007 .

[2]  J. Hale,et al.  Stability of Motion. , 1964 .

[3]  Laurent Pujo-Menjouet,et al.  Contribution to the study of periodic chronic myelogenous leukemia. , 2004, Comptes rendus biologies.

[4]  Antonis Papachristodoulou,et al.  Analysis of Polynomial Systems With Time Delays via the Sum of Squares Decomposition , 2009, IEEE Transactions on Automatic Control.

[5]  Martin A. Nowak,et al.  Dynamics of chronic myeloid leukaemia , 2005, Nature.

[6]  J. Altman,et al.  Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. , 1998, Immunity.

[7]  Adam Bagg,et al.  Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring. , 2002, The Journal of molecular diagnostics : JMD.

[8]  Helen Moore,et al.  A mathematical model for chronic myelogenous leukemia (CML) and T cell interaction. , 2004, Journal of theoretical biology.

[9]  Mark M. Davis,et al.  Evidence that specific T lymphocytes may participate in the elimination of chronic myelogenous leukemia , 2000, Nature Medicine.

[10]  Jos F. Sturm,et al.  A Matlab toolbox for optimization over symmetric cones , 1999 .

[11]  Gerhard Ehninger,et al.  Kinetics of stem cell engraftment and clearance of leukaemia cells after allogeneic stem cell transplantation with reduced intensity conditioning in chronic myeloid leukaemia , 2002, European journal of haematology.

[12]  Laurent Pujo-Menjouet,et al.  A mathematical model describing cellular division with a proliferating phase duration depending on the maturity of cells. , 2003 .

[13]  G. Weisbuch,et al.  Immunology for physicists , 1997 .

[14]  Richard J. Jones,et al.  Treatment options for chronic myeloid leukemia: imatinib versus interferon versus allogeneic transplant , 2004, Current opinion in oncology.

[15]  R. Larson,et al.  Perspectives on the treatment of chronic phase and advanced phase CML and Philadelphia chromosome positive ALL1 , 2003, Leukemia.

[16]  P. Paschka,et al.  Molecular monitoring of response to imatinib (Glivec®) in CML patients pretreated with interferon alpha. Low levels of residual disease are associated with continuous remission , 2003, Leukemia.

[17]  van der Arjan Schaft,et al.  Proceedings of the 47th IEEE Conference on Decision and Control, CDC 2008, December 9-11, 2008, Cancún, Mexico , 2008, CDC.

[18]  Susan O'Brien,et al.  Molecular Responses in Patients with Chronic Myelogenous Leukemia in Chronic Phase Treated with Imatinib Mesylate , 2005, Clinical Cancer Research.

[19]  Brent Neiman,et al.  A Mathematical Model of Chronic Myelogenous Leukemia , 2000 .

[20]  Matthew M. Peet,et al.  Exponentially Stable Nonlinear Systems Have Polynomial Lyapunov Functions on Bounded Regions , 2007, IEEE Transactions on Automatic Control.

[21]  Robert H. Collins,et al.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  Els Goulmy,et al.  Hematopoiesis-restricted minor histocompatibility antigens HA-1- or HA-2-specific T cells can induce complete remissions of relapsed leukemia , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[24]  Stephen P. Schoenberger,et al.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation , 2001, Nature Immunology.

[25]  SFT Thijsen,et al.  Chronic myeloid leukemia from basics to bedside , 1999, Leukemia.

[26]  Dominik Wodarz,et al.  Drug resistance in cancer: principles of emergence and prevention. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Alan S. Perelson,et al.  Stochastic stage-structured modeling of the adaptive immune system , 2003, Computational Systems Bioinformatics. CSB2003. Proceedings of the 2003 IEEE Bioinformatics Conference. CSB2003.

[28]  Michael C Mackey,et al.  A mathematical model of hematopoiesis: II. Cyclical neutropenia. , 2005, Journal of theoretical biology.

[29]  Patrick W Nelson,et al.  Mathematical analysis of delay differential equation models of HIV-1 infection. , 2002, Mathematical biosciences.

[30]  R. Larson,et al.  Imatinib induces hematologic and cytogenetic responses in patients with chronic myelogenous leukemia in myeloid blast crisis: results of a phase II study. , 2002, Blood.

[31]  J. B. Chatterjea,et al.  Chronic myelogenous leukaemia , 1973, Indian journal of pediatrics.

[32]  Jonas Mattsson,et al.  Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation. , 2003, Blood.

[33]  Michael C Mackey,et al.  A mathematical model of hematopoiesis--I. Periodic chronic myelogenous leukemia. , 2005, Journal of theoretical biology.

[34]  Ami Radunskaya,et al.  A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.

[35]  P. Klenerman,et al.  Low level viral persistence after infection with LCMV: a quantitative insight through numerical bifurcation analysis. , 2001, Mathematical biosciences.

[36]  Eric G. Pamer,et al.  Early Programming of T Cell Populations Responding to Bacterial Infection1 , 2000, The Journal of Immunology.

[37]  Susan M. Kaech,et al.  Memory CD8+ T cell differentiation: initial antigen encounter triggers a developmental program in naïve cells , 2001, Nature Immunology.

[38]  D. Neuberg,et al.  Toxicity and efficacy of defined doses of CD4(+) donor lymphocytes for treatment of relapse after allogeneic bone marrow transplant. , 1998, Blood.

[39]  Antonis Papachristodoulou,et al.  Positive Forms and Stability of Linear Time-Delay Systems , 2006, Proceedings of the 45th IEEE Conference on Decision and Control.

[40]  Carl T. Bergstrom,et al.  Models of CD8+ responses: 1. What is the antigen-independent proliferation program. , 2003, Journal of theoretical biology.

[41]  Yinyu Ye,et al.  DSDP5: Software for Semidefinite Programming , 2005 .

[42]  Frédéric Mazenc,et al.  Stability of a Gleevec and immune model with delays , 2008, 2008 47th IEEE Conference on Decision and Control.

[43]  Holden T Maecker,et al.  Development and dynamics of robust T-cell responses to CML under imatinib treatment. , 2008, Blood.

[44]  G. Stengle A nullstellensatz and a positivstellensatz in semialgebraic geometry , 1974 .

[45]  T. Klingebiel,et al.  GVHD: overview on pathophysiology, incidence, clinical and biological features. , 1998, Bone marrow transplantation.

[46]  A Ferrant,et al.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. , 1995, Blood.

[47]  Ingo Roeder,et al.  Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications , 2006, Nature Medicine.

[48]  C. Sawyers Chronic myeloid leukemia. , 1999, The New England journal of medicine.

[49]  Ju Hyun Park,et al.  Stability Analysis of Linear Time-delay Systems , 1996 .